{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:51:14Z","timestamp":1787611874862,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan Provincial Key Scientific Research Project Plan for Higher Education Institutions","award":["Grant No. 23A320019"],"award-info":[{"award-number":["Grant No. 23A320019"]}]},{"name":"Henan Provincial Medical Science and Technology Research Joint Venture Project","award":["Grant No. SBGJ202402040"],"award-info":[{"award-number":["Grant No. SBGJ202402040"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22195-9","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:54:27Z","timestamp":1762160067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dapagliflozin ameliorates high glucose-induced peritoneal fibrosis through downregulation of ENKUR\/PI3K\/AKT signaling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Jiahan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanzheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"2","key":"22195_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","volume":"13","author":"PK Li","year":"2017","unstructured":"Li, P. K. et al. Changes in the worldwide epidemiology of peritoneal Dialysis. Nat. Rev. Nephrol. 13(2), 90\u2013103 (2017).","journal-title":"Nat. Rev. Nephrol."},{"issue":"19","key":"22195_CR2","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMra2100152","volume":"385","author":"I Teitelbaum","year":"2021","unstructured":"Teitelbaum, I. Peritoneal Dialysis. N Engl. J. Med. 385(19), 1786\u20131795 (2021).","journal-title":"N Engl. J. Med."},{"issue":"5","key":"22195_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1681\/ASN.V1251046","volume":"12","author":"SJ Davies","year":"2001","unstructured":"Davies, S. J. et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal Dialysis. J. Am. Soc. Nephrol. 12(5), 1046\u20131051 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"22195_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams, J. D. et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol. 13(2), 470\u2013479 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"22195_CR5","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3747\/pdi.2017.00018","volume":"37","author":"EA Brown","year":"2017","unstructured":"Brown, E. A. et al. Length of time on peritoneal Dialysis and encapsulating peritoneal Sclerosis - Position paper for ISPD: 2017 update. Perit. Dial Int. 37(4), 362\u2013374 (2017).","journal-title":"Perit. Dial Int."},{"issue":"7","key":"22195_CR6","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2006111292","volume":"18","author":"LS Aroeira","year":"2007","unstructured":"Aroeira, L. S. et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal Dialysis patients: pathologic significance and potential therapeutic interventions. J. Am. Soc. Nephrol. 18(7), 2004\u20132013 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"22195_CR7","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa020809","volume":"348","author":"M Yanez-Mo","year":"2003","unstructured":"Yanez-Mo, M. et al. Peritoneal Dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl. J. Med. 348(5), 403\u2013413 (2003).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"22195_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1210\/jc.2009-0473","volume":"95","author":"S Nair","year":"2010","unstructured":"Nair, S. & Wilding, J. P. Sodium glucose cotransporter 2 inhibitors as a new treatment for diabetes mellitus. J. Clin. Endocrinol. Metab. 95(1), 34\u201342 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"22195_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.36628\/ijhf.2022.0030","volume":"5","author":"KM Talha","year":"2023","unstructured":"Talha, K. M., Anker, S. D. & Butler, J. SGLT-2 inhibitors in heart failure: A review of current evidence. Int. J. Heart Fail. 5(2), 82\u201390 (2023).","journal-title":"Int. J. Heart Fail."},{"issue":"2","key":"22195_CR10","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","volume":"6","author":"DK McGuire","year":"2021","unstructured":"McGuire, D. K. et al. Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: A Meta-analysis. JAMA Cardiol. 6(2), 148\u2013158 (2021).","journal-title":"JAMA Cardiol."},{"issue":"7951","key":"22195_CR11","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/d41586-023-00648-3","volume":"615","author":"AB Keener","year":"2023","unstructured":"Keener, A. B. SGLT2 inhibitors breathe life into kidney-disease care. Nature 615(7951), S2\u2013S4 (2023).","journal-title":"Nature"},{"issue":"5","key":"22195_CR12","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1046\/j.1523-1755.1998.00899.x","volume":"53","author":"B Schroppel","year":"1998","unstructured":"Schroppel, B. et al. Expression of glucose transporters in human peritoneal mesothelial cells. Kidney Int. 53(5), 1278\u20131287 (1998).","journal-title":"Kidney Int."},{"key":"22195_CR13","doi-asserted-by":"crossref","unstructured":"Balzer, M. S. et al. SGLT2 Inhibition by intraperitoneal Dapagliflozin mitigates peritoneal fibrosis and ultrafiltration failure in a mouse model of chronic peritoneal exposure to High-Glucose dialysate. Biomolecules 10(11) (2020).","DOI":"10.3390\/biom10111573"},{"key":"22195_CR14","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.biopha.2018.10.106","volume":"109","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. SGLT-2 inhibitors reduce glucose absorption from peritoneal Dialysis solution by suppressing the activity of SGLT-2. Biomed. Pharmacother. 109, 1327\u20131338 (2019).","journal-title":"Biomed. Pharmacother"},{"key":"22195_CR15","doi-asserted-by":"publisher","first-page":"107374","DOI":"10.1016\/j.intimp.2021.107374","volume":"93","author":"Y Shentu","year":"2021","unstructured":"Shentu, Y. et al. Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-beta\/Smad signaling. Int. Immunopharmacol. 93, 107374 (2021).","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"22195_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/08968608221080170","volume":"43","author":"G Martus","year":"2023","unstructured":"Martus, G., Bergling, K. & Oberg, C. M. Dual SGLT1\/SGLT2 inhibitor Phlorizin reduces glucose transport in experimental peritoneal Dialysis. Perit. Dial Int. 43(2), 145\u2013150 (2023).","journal-title":"Perit. Dial Int."},{"issue":"2","key":"22195_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ydbio.2004.07.031","volume":"274","author":"KA Sutton","year":"2004","unstructured":"Sutton, K. A. et al. Enkurin is a novel calmodulin and TRPC channel binding protein in sperm. Dev. Biol. 274(2), 426\u2013435 (2004).","journal-title":"Dev. Biol."},{"issue":"7","key":"22195_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3109\/0886022X.2013.808957","volume":"35","author":"J Zhang","year":"2013","unstructured":"Zhang, J. et al. Role of CIP4 in high glucose induced epithelial\u2013mesenchymal transition of rat peritoneal mesothelial cells. Ren. Fail. 35(7), 989\u2013995 (2013).","journal-title":"Ren. Fail."},{"issue":"17","key":"22195_CR19","doi-asserted-by":"publisher","first-page":"3975","DOI":"10.7150\/jca.30021","volume":"10","author":"Q Ma","year":"2019","unstructured":"Ma, Q. et al. ENKUR acts as a tumor suppressor in lung adenocarcinoma cells through PI3K\/Akt and MAPK\/ERK signaling pathways. J. Cancer. 10(17), 3975\u20133984 (2019).","journal-title":"J. Cancer"},{"issue":"10","key":"22195_CR20","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/s41401-022-00890-x","volume":"43","author":"JH Liu","year":"2022","unstructured":"Liu, J. H. et al. The small molecule chemical compound Cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma. Acta Pharmacol. Sin. 43(10), 2687\u20132695 (2022).","journal-title":"Acta Pharmacol. Sin"},{"key":"22195_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2022.01.025","volume":"531","author":"R Hou","year":"2022","unstructured":"Hou, R. et al. Chemically synthesized Cinobufagin suppresses nasopharyngeal carcinoma metastasis by inducing ENKUR to stabilize p53 expression. Cancer Lett. 531, 57\u201370 (2022).","journal-title":"Cancer Lett."},{"issue":"6","key":"22195_CR22","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.7150\/ijbs.67476","volume":"18","author":"R Hou","year":"2022","unstructured":"Hou, R. et al. ENKUR expression induced by chemically synthesized Cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating beta-catenin\/c-Jun\/MYH9\/USP7\/c-Myc axis. Int. J. Biol. Sci. 18(6), 2553\u20132567 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"22195_CR23","doi-asserted-by":"publisher","first-page":"973182","DOI":"10.3389\/fphar.2022.973182","volume":"13","author":"Q Huang","year":"2022","unstructured":"Huang, Q. et al. Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-beta\/ALK\/Smads signaling. Front. Pharmacol. 13, 973182 (2022).","journal-title":"Front. Pharmacol."},{"key":"22195_CR24","doi-asserted-by":"publisher","first-page":"897167","DOI":"10.3389\/fphar.2022.897167","volume":"13","author":"R Guo","year":"2022","unstructured":"Guo, R. et al. SGLT2 inhibitors suppress epithelial-mesenchymal transition in podocytes under diabetic conditions via downregulating the IGF1R\/PI3K pathway. Front. Pharmacol. 13, 897167 (2022).","journal-title":"Front. Pharmacol."},{"issue":"18","key":"22195_CR25","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s40265-019-01239-1","volume":"79","author":"S Dhillon","year":"2019","unstructured":"Dhillon, S. Correction to: Dapagliflozin: A review in type 2 diabetes. Drugs 79(18), 2013 (2019).","journal-title":"Drugs"},{"issue":"3","key":"22195_CR26","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.kint.2018.05.002","volume":"94","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice. Kidney Int. 94(3), 524\u2013535 (2018).","journal-title":"Kidney Int."},{"issue":"3","key":"22195_CR27","doi-asserted-by":"publisher","first-page":"F449","DOI":"10.1152\/ajprenal.00431.2018","volume":"316","author":"M Pirklbauer","year":"2019","unstructured":"Pirklbauer, M. et al. Unraveling reno-protective effects of SGLT2 Inhibition in human proximal tubular cells. Am. J. Physiol. Ren. Physiol. 316(3), F449\u2013F462 (2019).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"22195_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","volume":"18","author":"C Li","year":"2019","unstructured":"Li, C. et al. SGLT2 Inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc. Diabetol. 18(1), 15 (2019).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"22195_CR29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12916-022-02485-z","volume":"20","author":"SG Lee","year":"2022","unstructured":"Lee, S. G. et al. Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling. BMC Med. 20(1), 309 (2022).","journal-title":"BMC Med."},{"issue":"7","key":"22195_CR30","doi-asserted-by":"publisher","first-page":"e3000410","DOI":"10.1371\/journal.pbio.3000410","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 18(7), e3000410 (2020).","journal-title":"PLoS Biol."},{"issue":"8","key":"22195_CR31","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/j.ajpath.2015.04.008","volume":"185","author":"L He","year":"2015","unstructured":"He, L. et al. Twist contributes to proliferation and epithelial-to-mesenchymal transition-induced fibrosis by regulating YB-1 in human peritoneal mesothelial cells. Am. J. Pathol. 185(8), 2181\u20132193 (2015).","journal-title":"Am. J. Pathol."},{"key":"22195_CR32","doi-asserted-by":"crossref","unstructured":"Gonzalez-Mateo, G. T. et al. Surgical techniques for catheter placement and 5\/6 nephrectomy in murine models of peritoneal Dialysis. J. Vis. Exp.(2018).","DOI":"10.3791\/56746-v"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22195-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22195-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22195-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:02:18Z","timestamp":1762203738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22195-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22195"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22195-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study is reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"38334"}}